Floating for Chronic Pain
Float4Pain
1 other identifier
interventional
99
1 country
1
Brief Summary
In recent years there has been a novel approach for the treatment of chronic pain: Floatation REST (restricted environmental stimulation therapy). Floating is a therapeutic approach, in which patients float in a specialized pool or tank on water that contains high concentrations of Epsom salt (Magnesium sulfate). Water is kept at skin temperature (35-36°C) and the pool or tank is shielded to provide almost complete darkness and silence. This therapeutic approach has proven to be effective in alleviating chronic pain. Due to the difficulties associated with designing a credible placebo control there have been no randomized controlled trials (RCTs) with patients blinding so far. Such blinding, however, is crucial, to assess the true therapeutic effect of the intervention. The investigators will conduct the first patient blinded RCT of Floatation REST for chronic pain with a credible placebo control for floating and a no-treatment group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2018
CompletedStudy Start
First participant enrolled
June 26, 2018
CompletedFirst Posted
Study publicly available on registry
July 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 18, 2020
CompletedNovember 24, 2020
November 1, 2020
1.5 years
June 11, 2018
November 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Pain intensity (maximum and average) as compared to baseline
Numeric rating scales from 0 ("no pain") to 100 ("maximum imaginable pain"), assessing retrospectively the week before.
1, 12 and 24 weeks after intervention
Secondary Outcomes (22)
Change in Pain scores (maximum and average, dichotomous) as compared to baseline
1, 12 and 24 weeks after intervention
Change in pain-related disability as compared to baseline
1, 12 and 24 weeks after intervention
Change in trait anxiety as compared to baseline
1, 12 and 24 weeks after intervention
Change in depression as compared to baseline
1, 12 and 24 weeks after intervention
Change in physical and mental health as compared to baseline
1, 12 and 24 weeks after intervention
- +17 more secondary outcomes
Study Arms (3)
Intervention group
ACTIVE COMPARATORFloating
Control group
PLACEBO COMPARATORPlacebo floating
No-treatment group
NO INTERVENTIONWaiting list
Interventions
Floating in specialized tank with full floatation and sensory deprivation.
Floating in specialized tank with reduced floatation and sensory deprivation.
Eligibility Criteria
You may qualify if:
- Current diagnosis of chronic pain disorder with somatic and psychological factors (German ICD F45.41)
- Able and willing to give written informed consent
You may not qualify if:
- Pregnant or nursing women (self report)
- Previous experience with floating
- Acute illnesses that may exacerbate or shadow the chronic pain condition (acute inflammation, major depression, active neoplasm, etc.)
- History of alcohol and drug abuse
- Any clinically relevant abnormal findings in the clinical history, which, in the opinion of the investigator, may either put the subject at risk because of participation in the study or may influence the results of the study or the subject's ability to participate in the study.
- Any clinical condition that may prevent the subject from floating, such as: open injuries, contagious diseases (influenza, GI infections, athlete's foot), GERD, epilepsy, claustrophobia, schizophrenia, incontinence or acute skin disorders.
- Suspected inability to understand the protocol requirements, instructions and study-related restrictions, the nature, scope, and possible consequences of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hannover Medical School
Hanover, 30625, Germany
Related Publications (1)
Loose LF, Manuel J, Karst M, Schmidt LK, Beissner F. Flotation Restricted Environmental Stimulation Therapy for Chronic Pain: A Randomized Clinical Trial. JAMA Netw Open. 2021 May 3;4(5):e219627. doi: 10.1001/jamanetworkopen.2021.9627.
PMID: 33988708DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Florian Beissner, Dr. phil. nat.
Hannover Medical School
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 11, 2018
First Posted
July 12, 2018
Study Start
June 26, 2018
Primary Completion
January 2, 2020
Study Completion
June 18, 2020
Last Updated
November 24, 2020
Record last verified: 2020-11